Ethyl 1-[(3-Chlorobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate

ID: ALA4777430

PubChem CID: 162643178

Max Phase: Preclinical

Molecular Formula: C21H18ClN3O3

Molecular Weight: 395.85

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1c(C)nc(-c2cccc(C#N)c2)n1OCc1cccc(Cl)c1

Standard InChI:  InChI=1S/C21H18ClN3O3/c1-3-27-21(26)19-14(2)24-20(17-8-4-6-15(10-17)12-23)25(19)28-13-16-7-5-9-18(22)11-16/h4-11H,3,13H2,1-2H3

Standard InChI Key:  FYBZTHBJFKAELT-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   12.3679  -20.4586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3667  -21.2782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0748  -21.6871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7844  -21.2777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7816  -20.4550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0730  -20.0498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4856  -20.0454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2333  -20.3750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7779  -19.7656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3666  -19.0594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5679  -19.2324    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5909  -19.8480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6961  -18.3116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5085  -18.2230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2132  -17.6523    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8380  -17.4752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6503  -17.3867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0775  -22.5003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0773  -23.3175    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9586  -18.6880    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1823  -18.9435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5730  -18.3990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7433  -17.6026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1347  -17.0584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3575  -17.3138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1924  -18.1184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8023  -18.6591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3020  -16.2585    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  1  0
  5  7  1  0
  9 12  1  0
 10 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 18 19  3  0
  3 18  1  0
 11 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 24 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4777430

    ---

Associated Targets(non-human)

Plasma (649 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 395.85Molecular Weight (Monoisotopic): 395.1037AlogP: 4.19#Rotatable Bonds: 6
Polar Surface Area: 77.14Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.21CX LogP: 4.18CX LogD: 4.18
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -1.66

References

1. Lei Y,Zhang B,Liu D,Zhao J,Dai X,Gao J,Mao Q,Feng Y,Zhao J,Lin F,Duan Y,Zhang Y,Bao Z,Yang Y,Mou Y,Wang S.  (2020)  Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y and P2Y as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor.,  63  (24): [PMID:33307675] [10.1021/acs.jmedchem.0c01524]

Source